Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 6, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- September 4, 2006: Transfer of 10,687 Ordinary Shares.
- September 5, 2006: Transfer of 28,630 Ordinary Shares.
Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the GSK Trust as potential beneficiaries alongside other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the aforementioned share transactions in accordance with Disclosure Rule 3.1.4R(1)(b).
Key Facts for Investor Verification
- Verify the total number of shares transferred from the GSK Trust to the Employee Share Option Plan 1991 during the reporting period (39,317 shares total).
- Confirm the specific dates of the transactions (September 4 and September 5, 2006).
- Note that the GSK Trust is a discretionary trust for current and former employees, creating a potential interest for three named directors.